Thank you, Glenn, and good morning, everyone. Starting on Slide 7 with our term life segment. Operating revenues of $369 million increased 16% year-over-year, while operating income of $89 million grew 9%. The term life operating margin, which is typically lower in the fourth quarter due to seasonal persistency trends was 18.2%, down from 19.2% in the prior year period. COVID continued to have an impact on the quarter's results as did our annual actuarial assumption setting for 2020 business. Starting with COVID, the fourth quarter saw a significant rise in COVID related death claims combined with continued demand for life insurance in the form of both new sales and strong policy persistency. The number of policies issued increased 22% year-over-year, with the company reaching a record level of base amount issued in 2020. Higher sales, along with favorable persistency throughout the year, move the growth rate in adjusted direct premiums up to 15% year-over-year and added about $7 million to pretax income in the quarter. Persistency remained strong across all policy durations, with fourth quarter lapse rate nearly 30% lower in the aggregate year-over-year. Higher persistency resulted in $23 million lower DAC amortization and $13 million higher benefit reserve increases being recognized for a net contribution of $10 million to pretax income in the fourth quarter. We continue to attribute the strong persistency as well as elevated sales volumes to fears driven by the pandemic and expect levels to normalize as the risks associated with COVID subside. Looking at claims, we recorded an estimated $14 million of COVID related debt benefits, net of reinsurance during the quarter, the highest level since the onset of the pandemic. We previously estimated $9 million for the quarter based on 85,000 expected deaths in the US and Canada. However, with the spike in COVID related deaths in December, actual reported deaths in the population were 140,000. Our level of incurred losses in relation to total reported population deaths remain consistent with third quarter experience. When combining the net impact of COVID on sales, persistency and claims, we recognized an increase in pretax income of around $3 million for the quarter. Moving on to actuarial assumption setting. As we typically do in the fourth quarter, we locked in our GAAP actuarial assumptions for 2020 business this period. The most significant impact came from reducing the ultimate valuation rate from 5.3% to 4% to reflect the sustained low interest rate environment. Lowering the valuation rate pushes GAAP earnings out to later years, but it does not change the overall cash flows associated with the business. This change, along with a secondary impact of reflecting lower first duration lapses, resulted in a full year increase in benefit reserves of $5.5 million and a minor impact on DAC amortization being recognized in the quarter. To wrap up fourth quarter term life results, we saw year-over-year increases in both insurance commissions and insurance expenses. Insurance commissions increased with sales volumes as well as special licensing incentives to keep new recruits engaged and working towards permanent licensing. We largely funded these special initiatives with dollars that were originally earmarked for incentive trusts, which are typically recorded as insurance expenses. The increase in insurance expenses for the quarter was largely driven by growth in the business and technology initiatives. As we look to 2021, given the tailwind created by strong sales and persistency in 2020, we expect adjusted direct premiums to continue to grow in the 12% to 13% range on a full year basis, with higher growth rates earlier in the year that taper as the year unfolds. The uncertainty surrounding the COVID pandemic make it particularly difficult to project our results. In general terms, we believe COVID related deaths, and likewise, the sales and policy persistency will remain high for the first half of 2021. We currently estimate first quarter 2021 claims at approximately $21 million, which is based on a projection of 210,000 deaths in the US and Canada. As more people become vaccinated, the level of COVID deaths should decline significantly with our benefits and claims ratio reverting to between 58% to 59% in the latter part of the year. We continue to believe the unusually strong level of persistency experienced in 2020 is not sustainable long term. The pace and extent to which persistency normalizes will likely be correlated to how quickly COVID fear subside, combined with the health of the economy in 2021. Turning now to our Investment and Savings Products segment on Slide 8. Operating revenues of $193 million increased 6% and pretax income of $57 million rose 7%. Sales based revenues were largely unchanged year-over-year, although, revenue generating sales increased 5%. Looking at the competition of product sales with yields at mutual funds which have a lower sales based commission rate were up 17%, while annuity sales declined 15%. Asset based revenues were up 11% in line with the increase in average client asset values. Expenses from both sales and asset based commissions moved in correlation with their respective revenues. Canadian segregated fund DAC amortization continued to be low due to favorable market performance and redemption levels. In our Corporate and Other Distributed Products segment on Slide 9, our operating loss grew by $4.3 million. Consolidated net investment income was flat year-over-year as growth in the size of the portfolio largely offset the impact of lower interest rates. On a segment basis, NII reported in the Corporate and Other segment was down $2.2 million as we continue to allocate a larger portion of NII to the term life segment in support of the growing block of business. Benefits and claims were $2.1 million higher year-over-year, largely due to a reserve adjustment on a closed block of business to reflect the sustained low interest rate environment. In both the current and prior year periods, there were charges in the $2 million range associated with reinsurance on closed blocks that largely offset each other. The mortgage distribution business added $3.7 million of revenue to pretax income during the quarter. To help track the performance of this business, we’ve added closed US mortgage volume and commission revenue received on mortgage loans to our financial supplement. On Slide 10, consolidated insurance and other operating expenses were $113 million during the fourth quarter, increasing 6% year over year and in line with our prior guidance. Approximately a third of the increase was due to continued investments in various technology initiatives while the remainder was comprised of expenses that took force to growth in our business and higher employee related costs. Looking ahead to 2021, we anticipate insurance and other operating expenses will increase between $40 million and $45 million or 9% to 10% year-over-year. We expect about 40% of the increase to hit the term life segment, with the remaining increase led fairly evenly between ISP and corporate and others. About a third or $15 million of the total increase is tied directly to revenue sources such as premium taxes, ISP asset based fees and record keeping fees. Salaries and benefit related expenses are expected to be about $10 million higher year-over-year. This increase is larger than normal due to unusually low licensing, instructor salaries during 2020 as fewer pre licensing classes were held as a result of COVID. We also experienced lower travel related expenses during 2020. And while we expect COVID related travel restrictions to remain in place through the first half of the year, we do expect normalization later in 2021, adding about $2 million in expenses. We will continue to invest in priorities to grow the business and provide tools for our agents and employees. Continued investment in technology will add approximately $5 million to our operating expense base. Strategic enhancements to our business platforms, including adding stakes to our mortgage distribution business, introducing life wholesalers to support the sales force, evaluating deferred sales charge alternatives in Canada and expanding our lifetime investment platform, will add about $12 million in related expenses. As Glenn mentioned, we are rescheduling our biannual convention to the summer of 2022 and will conduct virtual meetings and special incentives in 2021 to help sustain momentum. When comparing this to the field meeting and incentives we conducted in 2020, we expect about a $4 million year-over-year reduction in meeting related insurance and other operating expenses in 2021. Turning to Slide 11. Our invested assets portfolio remains well diversified across industries and issuers. The company's invested asset portfolio has performed well during 2020 with only modest impairments. At year-end, the net unrealized gain was $153 million and the average credit rating is A. Finally, on Slide 12, liquidity at the holding company remained very strong with invested assets in cash of $350 million at year end. And Primerica Life's statutory risk based capital ratio estimated to be around 400%. The ratio fell from the prior quarter level as economic reserves on one of our captive entities were higher than expected due to higher persistency. We're comfortable with RBC at this level and expect it to increase somewhat in 2021. With that, operator, I open the line up for questions.